Iovance Biotherapeutics Inc (IOVA) — Financial Flexibility Index
Iovance Biotherapeutics Inc (IOVA) has a Financial Flexibility Index of -0.33x as of September 2025. Free cash flow of $-67.86 Million (operating CF $-78.70 Million minus capex $10.84 Million) represents 0% of total liabilities ($202.66 Million). Check Iovance Biotherapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Iovance Biotherapeutics Inc Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Iovance Biotherapeutics Inc across 17 annual periods. For the full cash flow conversion analysis, see IOVA cash flow conversion.
Annual Financial Flexibility Index for Iovance Biotherapeutics Inc (2008–2024)
Year-by-year free cash flow to debt coverage for Iovance Biotherapeutics Inc. Explore IOVA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.71x | $-341.91 Million | $-352.98 Million | $200.02 Million | ▲ +1.5% |
| 2023 | -1.73x | $-339.53 Million | $-361.82 Million | $195.74 Million | ▼ -4.7% |
| 2022 | -1.66x | $-272.33 Million | $-292.76 Million | $164.34 Million | ▼ -35.5% |
| 2021 | -1.22x | $-190.37 Million | $-227.94 Million | $155.67 Million | ▲ +13.5% |
| 2020 | -1.41x | $-158.34 Million | $-205.13 Million | $111.96 Million | ▲ +57.5% |
| 2019 | -3.33x | $-151.97 Million | $-158.89 Million | $45.68 Million | ▲ +51.4% |
| 2018 | -6.84x | $-100.05 Million | $-101.25 Million | $14.63 Million | ▲ +12.9% |
| 2017 | -7.85x | $-77.68 Million | $-78.71 Million | $9.89 Million | ▼ -25.3% |
| 2016 | -6.27x | $-31.15 Million | $-32.67 Million | $4.97 Million | ▲ +40.7% |
| 2015 | -10.58x | $-17.24 Million | $-18.38 Million | $1.63 Million | ▼ -149.6% |
| 2014 | -4.24x | $-7.04 Million | $-8.63 Million | $1.66 Million | ▼ -163.5% |
| 2013 | -1.61x | $-3.65 Million | $-3.66 Million | $2.27 Million | ▼ -714.0% |
| 2012 | -0.20x | $-2.24 Million | $-2.24 Million | $11.35 Million | ▲ +57.2% |
| 2011 | -0.46x | $-6.16 Million | $-6.19 Million | $13.35 Million | ▲ +38.9% |
| 2010 | -0.75x | $-620.80K | $-620.80K | $822.87K | ▼ -20.7% |
| 2009 | -0.62x | $-14.45K | $-14.45K | $23.12K | ▲ +96.4% |
| 2008 | -17.22x | $-57.30K | $-57.30K | $3.33K | — |